Cargando…
Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach
Amyotrophic lateral sclerosis (ALS) is one of the most common motor neurodegenerative disorders, primarily affecting upper and lower motor neurons in the brain, brainstem, and spinal cord, resulting in paralysis due to muscle weakness and atrophy. The majority of patients die within 3–5 years of sym...
Autores principales: | Kumar, Alok, Ghosh, Devlina, Singh, R. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437352/ https://www.ncbi.nlm.nih.gov/pubmed/26317018 http://dx.doi.org/10.1155/2013/538765 |
Ejemplares similares
-
Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
por: Cieślak, M., et al.
Publicado: (2018) -
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
por: Guo, Wenting, et al.
Publicado: (2020) -
Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019) -
Implications of white matter damage in amyotrophic lateral sclerosis
por: Zhou, Ting, et al.
Publicado: (2017) -
Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)